Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitive Deficit in Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00604760
What this trial is testing

Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Memory Pharmaceuticals 160
Not applicableStudy completedNCT06155786
What this trial is testing

Cognitive Effects of tDCS and tRNS in Schizophrenia

Who this might be right for
SchizophreniaCognitive Impairment
The National Brain Mapping Laboratory (NBML) 36
Not applicableNot Yet RecruitingNCT06474286
What this trial is testing

Prucalopride for Cognitive Functioning in Schizophrenia

Who this might be right for
Schizophrenia
University of Pittsburgh 34
Not applicableActive Not RecruitingNCT05857137
What this trial is testing

Psychosis TMS Study

Who this might be right for
Psychosis
Massachusetts General Hospital 20
Not applicableNot Yet RecruitingNCT07404319
What this trial is testing

Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaTreatment Resistant SchizophreniaCognitive Impairment
Kit Wa Chan 160
Not applicableEnrolling By InvitationNCT07074704
What this trial is testing

TACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.

Who this might be right for
Negative Symptoms in SchizophreniaCognition Function
Tongji University 60
Very early researchStudy completedNCT01181934
What this trial is testing

The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.

Who this might be right for
SchizophreniaCognition Disorders
Janssen Pharmaceutica N.V., Belgium 32
Not applicableStudy completedNCT03273439
What this trial is testing

RTMS for Cognitive Deficits in Chronic Patients With Schizophrenia

Who this might be right for
Schizophrenia
Suzhou Psychiatric Hospital 47
Not applicableStudy completedNCT03388554
What this trial is testing

The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderAuditory Hallucination, Verbal+4 more
Tri-Service General Hospital (TSGH) 60
Large-scale testing (Phase 3)Study completedNCT05838573
What this trial is testing

Metformin Treatment on Cognitive Impairment of Schizophrenia

Who this might be right for
Schizophrenia
Central South University 120
Not applicableStudy completedNCT01773239
What this trial is testing

Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia

Who this might be right for
Schizophrenia
Posit Science Corporation 16
Not applicableNot Yet RecruitingNCT07806877
What this trial is testing

Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia

Who this might be right for
Schizophrenia / Schizoaffective DisorderTMSCognitive+1 more
Central South University 60
Testing effectiveness (Phase 2)Study completedNCT01678755
What this trial is testing

Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Who this might be right for
Schizophrenia
AbbVie (prior sponsor, Abbott) 157
Testing effectiveness (Phase 2)Study completedNCT00482430
What this trial is testing

MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)

Who this might be right for
Paranoid SchizophreniaSchizophrenia
Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)Ended earlyNCT02855411
What this trial is testing

Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Biogen 35
Large-scale testing (Phase 3)Ended earlyNCT00148616
What this trial is testing

Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
M. Schaefer, MD 13
Not applicableStudy completedNCT04768335
What this trial is testing

Auditory Processes and Emotional Perception in Schizophrenia

Who this might be right for
Basic Auditory ProcessesEmotional PerceptionSource Monitoring Deficits
Hôpital le Vinatier 50
Testing effectiveness (Phase 2)Study completedNCT00061789
What this trial is testing

Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 100
Testing effectiveness (Phase 2)Study completedNCT01488929
What this trial is testing

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Who this might be right for
SchizophreniaNegative SymptomsCognitive Dysfunction
Targacept Inc. 603
Testing effectiveness (Phase 2)Study completedNCT00528905
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 400
Next Page